Rincon Bio performs VCaP xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
Organism: Homo sapiens, human / Cell Type: epithelial / Tissue: prostate; derived from metastatic site: vertebral metastasis / Disease: cancer
VCaP cells were derived in 1997 from a 59 year old male caucasian with hormone refractory prostate cancer. It is androgen sensitive in vitro and in vivo
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
Rincon Bio Growth Curve
Cell Line: VCAP
Mouse Strain: R2G2 (Envigo)
Cells Implanted per Animal: 3 x 10^6
WHY WORK WITH
DOMESTIC QUALITY at COMPETITIVE PRICES
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
SPEED TO INITIATION
Most efficacy studies can be initiated within two business days.
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.